UChicago Cancer
@uchicagocancer.bsky.social
Joint account for the NCI-designated UChicago Medicine Comprehensive Cancer Center and the University of Chicago's Section of Hematology/Oncology.
At the forefront of clinical care, research, and education. https://www.uchicagomedicine.org/cancer
At the forefront of clinical care, research, and education. https://www.uchicagomedicine.org/cancer
A new study shows that inflammation caused by exposure to excessive sunlight degrades YTHDF2, a key protein that protects normal skin cells from turning cancerous, pointing towards ways to prevent skin cancer. UChicago Cancer @uchichemistry.bsky.social UChicagoBSD
https://ow.ly/Z8hl50XrS8w
https://ow.ly/Z8hl50XrS8w
November 14, 2025 at 8:13 PM
A new study shows that inflammation caused by exposure to excessive sunlight degrades YTHDF2, a key protein that protects normal skin cells from turning cancerous, pointing towards ways to prevent skin cancer. UChicago Cancer @uchichemistry.bsky.social UChicagoBSD
https://ow.ly/Z8hl50XrS8w
https://ow.ly/Z8hl50XrS8w
A new study shows that inflammation caused by excessive sunlight degrades YTHDF2, a key protein that protects normal skin skin cells from turning cancerous, pointing towards ways to prevent skin cancer. UChicago Cancer @uchichemistry.bsky.social @UChicagoBSD
https://ow.ly/Z8hl50XrS8w
https://ow.ly/Z8hl50XrS8w
November 14, 2025 at 5:56 PM
A new study shows that inflammation caused by excessive sunlight degrades YTHDF2, a key protein that protects normal skin skin cells from turning cancerous, pointing towards ways to prevent skin cancer. UChicago Cancer @uchichemistry.bsky.social @UChicagoBSD
https://ow.ly/Z8hl50XrS8w
https://ow.ly/Z8hl50XrS8w
🔥Hot off the press: Chuan He, PhD and his team have developed a novel methylation analysis method called ultra-mild bisulfite sequencing, which detects epigenetic changes in cancers more quickly, accurately, and reliably than existing methods. @uchichemistry.bsky.social
https://ow.ly/ALtf50XrlC4
https://ow.ly/ALtf50XrlC4
November 13, 2025 at 9:04 PM
🔥Hot off the press: Chuan He, PhD and his team have developed a novel methylation analysis method called ultra-mild bisulfite sequencing, which detects epigenetic changes in cancers more quickly, accurately, and reliably than existing methods. @uchichemistry.bsky.social
https://ow.ly/ALtf50XrlC4
https://ow.ly/ALtf50XrlC4
🔥Hot off the press: In a new study, UChicago Cancer researchers show that restoring YTHDF2 function prevents normal skin cells from turning cancerous after excessive sun exposure. #UVRadiation #SkinCancer #Inflammation Nature Communications
https://www.nature.com/articles/s41467-025-64898-7
https://www.nature.com/articles/s41467-025-64898-7
November 12, 2025 at 6:45 PM
🔥Hot off the press: In a new study, UChicago Cancer researchers show that restoring YTHDF2 function prevents normal skin cells from turning cancerous after excessive sun exposure. #UVRadiation #SkinCancer #Inflammation Nature Communications
https://www.nature.com/articles/s41467-025-64898-7
https://www.nature.com/articles/s41467-025-64898-7
In a recent interview with OncLive, Wendy Stock, MD, discussed the growing role of TKIs in Ph-positive ALL, the impact of molecular monitoring on treatment optimization to maximize efficacy and safety/quality of life.
https://ow.ly/OyAG50Xq7zU
https://ow.ly/OyAG50Xq7zU
November 11, 2025 at 6:13 PM
In a recent interview with OncLive, Wendy Stock, MD, discussed the growing role of TKIs in Ph-positive ALL, the impact of molecular monitoring on treatment optimization to maximize efficacy and safety/quality of life.
https://ow.ly/OyAG50Xq7zU
https://ow.ly/OyAG50Xq7zU
🎙️In the latest episode of The Director, Drs. Odunsi and Mesa emphasize that diversity, international collaboration, and continuous funding support are essential to bring transformative cancer therapies to clinics. Ruben A. Mesa, MD, FACP The Cancer Letter
https://ow.ly/Z8NR50XpG05
https://ow.ly/Z8NR50XpG05
November 10, 2025 at 9:36 PM
🎙️In the latest episode of The Director, Drs. Odunsi and Mesa emphasize that diversity, international collaboration, and continuous funding support are essential to bring transformative cancer therapies to clinics. Ruben A. Mesa, MD, FACP The Cancer Letter
https://ow.ly/Z8NR50XpG05
https://ow.ly/Z8NR50XpG05
📕New in Journal of Experimental Medicine: Chen et al., show that radiotherapy may promote metastasis by upregulating YTHDF2 in dendritic cells, impairing MHC-1 cross presentation and CD8+ T cell activation.
Ludwig Cancer Research
https://ow.ly/BAeq50Xown3
Ludwig Cancer Research
https://ow.ly/BAeq50Xown3
November 7, 2025 at 5:42 PM
📕New in Journal of Experimental Medicine: Chen et al., show that radiotherapy may promote metastasis by upregulating YTHDF2 in dendritic cells, impairing MHC-1 cross presentation and CD8+ T cell activation.
Ludwig Cancer Research
https://ow.ly/BAeq50Xown3
Ludwig Cancer Research
https://ow.ly/BAeq50Xown3
Researcher at the University of Chicago have developed a modular "plug-and-play" immune cell design that could make cancer immunotherapy treatments faster, smarter, and more adaptable.
#Immunotherapy #CART #NovelCancerTreatments
Read full story: https://ow.ly/mhpU50XnnNi
#Immunotherapy #CART #NovelCancerTreatments
Read full story: https://ow.ly/mhpU50XnnNi
November 5, 2025 at 8:53 PM
Researcher at the University of Chicago have developed a modular "plug-and-play" immune cell design that could make cancer immunotherapy treatments faster, smarter, and more adaptable.
#Immunotherapy #CART #NovelCancerTreatments
Read full story: https://ow.ly/mhpU50XnnNi
#Immunotherapy #CART #NovelCancerTreatments
Read full story: https://ow.ly/mhpU50XnnNi
Check out the inspiring story of Crystal Hendricks-Kretzer — a breast cancer survivor who benefited from a clinical trial that offered personalized breast cancer treatment using a novel antibody-drug conjugate. #BreastCancer #ClinicalTrials
https://ow.ly/46Zu50XmMAm
https://ow.ly/46Zu50XmMAm
November 5, 2025 at 8:24 PM
Check out the inspiring story of Crystal Hendricks-Kretzer — a breast cancer survivor who benefited from a clinical trial that offered personalized breast cancer treatment using a novel antibody-drug conjugate. #BreastCancer #ClinicalTrials
https://ow.ly/46Zu50XmMAm
https://ow.ly/46Zu50XmMAm
Check out the inspiring story of Crystal Hendricks-Kretzer — a breast cancer survivor who benefited from a clinical trial that offered personalized breast cancer treatment using a novel antibody-drug conjugate. #BreastCancer #ClinicalTrials @UCh
https://ow.ly/46Zu50XmMAm
https://ow.ly/46Zu50XmMAm
November 4, 2025 at 8:48 PM
Check out the inspiring story of Crystal Hendricks-Kretzer — a breast cancer survivor who benefited from a clinical trial that offered personalized breast cancer treatment using a novel antibody-drug conjugate. #BreastCancer #ClinicalTrials @UCh
https://ow.ly/46Zu50XmMAm
https://ow.ly/46Zu50XmMAm
We were delighted to honor Monica Bertagnolli, MD, former @NIH and the NCI director, with the 2025 Simon M. Shubitz Prize for her leadership in oncology and commitment to advancing equitable cancer care.
UChicagoBSD
@uchicagomedicine.bsky.social
https://ow.ly/vppj50XjTLY
UChicagoBSD
@uchicagomedicine.bsky.social
https://ow.ly/vppj50XjTLY
October 30, 2025 at 4:26 PM
We were delighted to honor Monica Bertagnolli, MD, former @NIH and the NCI director, with the 2025 Simon M. Shubitz Prize for her leadership in oncology and commitment to advancing equitable cancer care.
UChicagoBSD
@uchicagomedicine.bsky.social
https://ow.ly/vppj50XjTLY
UChicagoBSD
@uchicagomedicine.bsky.social
https://ow.ly/vppj50XjTLY
Congrats to Thomas Gajewski, MD, PhD, on the 2025 AACI Distinguished Scientist Award recognizing his pioneering research in tumor immunology and immunotherapy.
UChicagoBSD
University of Chicago Pathology
@uchicagomedicine.bsky.social
https://ow.ly/JMey50Xh2oA
UChicagoBSD
University of Chicago Pathology
@uchicagomedicine.bsky.social
https://ow.ly/JMey50Xh2oA
October 29, 2025 at 3:47 PM
Congrats to Thomas Gajewski, MD, PhD, on the 2025 AACI Distinguished Scientist Award recognizing his pioneering research in tumor immunology and immunotherapy.
UChicagoBSD
University of Chicago Pathology
@uchicagomedicine.bsky.social
https://ow.ly/JMey50Xh2oA
UChicagoBSD
University of Chicago Pathology
@uchicagomedicine.bsky.social
https://ow.ly/JMey50Xh2oA
A recent study in Nature Cell Biology demonstrates that two microbial metabolites act in opposite ways on cell growth. Notably, pre-queuosine 1 inhibits cell proliferation, offering potential for the development of novel cancer therapies. @UChicagoBSD
https://ow.ly/5xS350Xjgab
https://ow.ly/5xS350Xjgab
October 28, 2025 at 5:53 PM
A recent study in Nature Cell Biology demonstrates that two microbial metabolites act in opposite ways on cell growth. Notably, pre-queuosine 1 inhibits cell proliferation, offering potential for the development of novel cancer therapies. @UChicagoBSD
https://ow.ly/5xS350Xjgab
https://ow.ly/5xS350Xjgab
Join us for the 2025 Simon M. Shubitz Cancer Prize & Lectureship featuring Monica Bertagnolli, MD, a renowned surgical oncologist and physician-scientist, and former director of the National Institutes of Health.
#HarvardKennedySchool
📅October 27
⏰12 PM CST
Room: KCBD 1103
#HarvardKennedySchool
📅October 27
⏰12 PM CST
Room: KCBD 1103
October 27, 2025 at 4:32 PM
Join us for the 2025 Simon M. Shubitz Cancer Prize & Lectureship featuring Monica Bertagnolli, MD, a renowned surgical oncologist and physician-scientist, and former director of the National Institutes of Health.
#HarvardKennedySchool
📅October 27
⏰12 PM CST
Room: KCBD 1103
#HarvardKennedySchool
📅October 27
⏰12 PM CST
Room: KCBD 1103
Kathleen Humphries hadn’t had a mammogram in over 10 years when a screening at UChicago Medicine revealed stage 2 breast cancer. Thanks to early detection, expert care and the support of lifelong friends, Kathleen is on the path to recovery.
https://ow.ly/EIn450Xisgr
https://ow.ly/EIn450Xisgr
October 27, 2025 at 3:57 PM
Kathleen Humphries hadn’t had a mammogram in over 10 years when a screening at UChicago Medicine revealed stage 2 breast cancer. Thanks to early detection, expert care and the support of lifelong friends, Kathleen is on the path to recovery.
https://ow.ly/EIn450Xisgr
https://ow.ly/EIn450Xisgr
A recent study found that #FearofCancerRecurrence was higher among breast cancer patients diagnosed at younger ages, those experiencing stress, recurrent disease, or ER‐positive cancer, highlighting the need for psychosocial support in survivorship care. ow.ly/giAw50XhaZ5
October 23, 2025 at 8:46 PM
A recent study found that #FearofCancerRecurrence was higher among breast cancer patients diagnosed at younger ages, those experiencing stress, recurrent disease, or ER‐positive cancer, highlighting the need for psychosocial support in survivorship care. ow.ly/giAw50XhaZ5
Congrats to Thomas Gajewski, MD, PhD, on the 2025 AACI Distinguished Scientist Award recognizing his pioneering research tumor immunology and immunotherapy.
ow.ly/JMey50Xh2oA
ow.ly/JMey50Xh2oA
October 23, 2025 at 5:57 PM
Congrats to Thomas Gajewski, MD, PhD, on the 2025 AACI Distinguished Scientist Award recognizing his pioneering research tumor immunology and immunotherapy.
ow.ly/JMey50Xh2oA
ow.ly/JMey50Xh2oA
UChicago Medicine Comprehensive Cancer Center is partnering with the #AmericanCancerSociety on an upcoming #MakingStridesAgainstBreastCancer event in Downtown Chicago. Join the forces by supporting the nation’s largest and most impactful breast cancer movement. @acscan.bsky.social
October 17, 2025 at 6:14 PM
UChicago Medicine Comprehensive Cancer Center is partnering with the #AmericanCancerSociety on an upcoming #MakingStridesAgainstBreastCancer event in Downtown Chicago. Join the forces by supporting the nation’s largest and most impactful breast cancer movement. @acscan.bsky.social
A new study published in @gimjournal.bsky.social suggests addressing health literacy gaps about polygenic risk scores may help support informed decision-making among breast cancer patients from racial/ethnic minority backgrounds.
ow.ly/UaXt50XbZ3g
ow.ly/UaXt50XbZ3g
October 15, 2025 at 6:53 PM
A new study published in @gimjournal.bsky.social suggests addressing health literacy gaps about polygenic risk scores may help support informed decision-making among breast cancer patients from racial/ethnic minority backgrounds.
ow.ly/UaXt50XbZ3g
ow.ly/UaXt50XbZ3g
#TBT to last weekend's South Side Science Festival!! Hosted on campus and open to community members of all ages, we spent the day celebrating science and curiosity!
#UniversityofChicago #AtTheForefront #medSky #ScienceIsForEveryone #EducationSky #OncSky
#UniversityofChicago #AtTheForefront #medSky #ScienceIsForEveryone #EducationSky #OncSky
October 10, 2025 at 2:57 PM
#TBT to last weekend's South Side Science Festival!! Hosted on campus and open to community members of all ages, we spent the day celebrating science and curiosity!
#UniversityofChicago #AtTheForefront #medSky #ScienceIsForEveryone #EducationSky #OncSky
#UniversityofChicago #AtTheForefront #medSky #ScienceIsForEveryone #EducationSky #OncSky
A new #NCCN study finds that "quitting smoking" benefits cancer patients, even after a late-stage diagnosis. Including smoking cessation as a core part of the treatment plan may improve quality of life and increase survival rates. ow.ly/RJMV50X9iUb
ow.ly/4aHN50X9iUc
ow.ly/4aHN50X9iUc
October 9, 2025 at 5:14 PM
A new #NCCN study finds that "quitting smoking" benefits cancer patients, even after a late-stage diagnosis. Including smoking cessation as a core part of the treatment plan may improve quality of life and increase survival rates. ow.ly/RJMV50X9iUb
ow.ly/4aHN50X9iUc
ow.ly/4aHN50X9iUc
UChicago Medicine team "Thoracic Park" participated in the Lung Cancer Research Foundation’s annual Free to Breathe Chicago Walk on Sunday, October 5 and raised more than $2,500.
October 9, 2025 at 4:28 PM
UChicago Medicine team "Thoracic Park" participated in the Lung Cancer Research Foundation’s annual Free to Breathe Chicago Walk on Sunday, October 5 and raised more than $2,500.
Check out the latest updates from the NCCN on NSCLC treatment guidelines, emphasizing the incorporation of immune checkpoint inhibitors and targeted therapies in the management of resectable NSCLC.
ow.ly/Bfz450WVq2n
ow.ly/Bfz450WVq2n
September 11, 2025 at 7:48 PM
Check out the latest updates from the NCCN on NSCLC treatment guidelines, emphasizing the incorporation of immune checkpoint inhibitors and targeted therapies in the management of resectable NSCLC.
ow.ly/Bfz450WVq2n
ow.ly/Bfz450WVq2n
Looking forward to the upcoming Jonas Center Cellular Therapy Symposium? Don't forget about the satellite symposium the day before, perfect for trainees and emerging scientists on your team! Registration (free of charge!) can be found at www.jonascentersymposium.com/satellite-sy...
September 9, 2025 at 7:59 PM
Looking forward to the upcoming Jonas Center Cellular Therapy Symposium? Don't forget about the satellite symposium the day before, perfect for trainees and emerging scientists on your team! Registration (free of charge!) can be found at www.jonascentersymposium.com/satellite-sy...
In a new commentary Freeman et al. points out that patients with ER-low tumors may not benefit from estrogen therapy in adjuvant setting, suggesting re-evaluation of systemic treatment strategies. #ERLowBreastCancer #PrecisionMedicine
@uchicagoobgyn.bsky.social
ow.ly/Leto50WObj7
@uchicagoobgyn.bsky.social
ow.ly/Leto50WObj7
August 29, 2025 at 2:39 PM
In a new commentary Freeman et al. points out that patients with ER-low tumors may not benefit from estrogen therapy in adjuvant setting, suggesting re-evaluation of systemic treatment strategies. #ERLowBreastCancer #PrecisionMedicine
@uchicagoobgyn.bsky.social
ow.ly/Leto50WObj7
@uchicagoobgyn.bsky.social
ow.ly/Leto50WObj7